Stay updated on SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial

Sign up to get notified when there's something new on the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-03T23:53:07.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A site-wide NIH announcement about using “Super Intelligence” in place of “Artificial Intelligence” appears above the page, and the site revision advances from v3.7.1 to v3.7.2. The study record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-27T23:53:21.000Z thumbnail image
  3. Check
    29 days ago
    Change Detected
    Summary
    The footer’s site revision marker changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-07T00:17:12.000Z thumbnail image
  4. Check
    43 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study content with an access-denied screen. This indicates a site access issue rather than a change to the study information itself.
    Difference
    18%
    Check dated 2026-09-23T00:06:42.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Revision updated to v3.7.0 in the Study Documents section, replacing the previous v3.6.6. This reflects an updated set of trial documents.
    Difference
    0.0%
    Check dated 2026-09-16T00:08:10.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.6.6, replacing the previous v3.6.5. This indicates a minor maintenance update without changes to study details or patient-facing information.
    Difference
    0.0%
    Check dated 2026-09-01T19:13:27.000Z thumbnail image

Stay in the know with updates to SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page.